INACTIVATION OF A TUMOR SUPPRESSOR FUNCTION IN IMMORTAL SYRIAN-HAMSTER CELLS BY N-METHYL-N'-NITRO-N-NITROSOGUANIDINE AND BY 5-AZA-2'-DEOXYCYTIDINE

被引:108
作者
WEST, RW [1 ]
BARRETT, JC [1 ]
机构
[1] NIEHS,MOLEC CARCINOGENESIS LAB,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1093/carcin/14.2.285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clonal lines of immortal Syrian hamster cells were previously isolated that either suppressed (supB+) tumorigenicity in hybrids with a malignant hamster cell line (BP6T) or had lost this suppression ability (supB-). Neither line was tumorigenic or showed anchorage-independent growth in normal growth medium. SupB- cells, but not supB+ cells, grew in agar supplemented with the growth factors EGF. PDGF and insulin (EPI), providing a selective assay for the supB- phenotype. After treatment of supB+ cells with either N-methyl-N'-nitro-N-nitrosoguanidine (10-300 ng/ml) or 5-aza-2'-deoxycytidine (25-250 ng/ml), and an expression period of 4-8 weeks, a dose-dependent increase in altered cells that grew in agar supplemented with EPI was observed. Cell lines derived from colonies in agar showed persistent EPI-stimulated growth in agar, and decreased suppression of growth in agar for hybrids with BP6T cells. Thus, carcinogen-induced loss of the tumor suppressor phenotype has been demonstrated.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 27 条
[1]   EVIDENCE FOR PROGRESSIVE NATURE OF NEOPLASTIC TRANSFORMATION INVITRO [J].
BARRETT, JC ;
TSO, POP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (08) :3761-3765
[2]   RELATIONSHIP BETWEEN SOMATIC MUTATION AND NEOPLASTIC TRANSFORMATION [J].
BARRETT, JC ;
TSO, POP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (07) :3297-3301
[3]  
BAYLIN SB, 1991, CANCER CELL-MON REV, V3, P383
[4]   TUMOR SUPPRESSOR GENES - POSSIBLE FUNCTIONS IN THE NEGATIVE REGULATION OF CELL-PROLIFERATION [J].
BOYD, JA ;
BARRETT, JC .
MOLECULAR CARCINOGENESIS, 1990, 3 (06) :325-329
[5]   A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS [J].
CAWTHON, RM ;
WEISS, R ;
XU, GF ;
VISKOCHIL, D ;
CULVER, M ;
STEVENS, J ;
ROBERTSON, M ;
DUNN, D ;
GESTELAND, R ;
OCONNELL, P ;
WHITE, R .
CELL, 1990, 62 (01) :193-201
[6]  
FUTREAL PA, 1991, ONCOGENE, V6, P1109
[7]   GENETIC-EFFECTS OF N-METHYL-N'-NITRO-N-NITROSOGUANIDINE AND ITS HOMOLOGS [J].
GICHNER, T ;
VELEMINSKY, J .
MUTATION RESEARCH, 1982, 99 (02) :129-242
[8]  
GLOVER AB, 1987, CANCER TREAT REP, V71, P959
[9]  
HARRIS H, 1988, CANCER RES, V48, P3302
[10]   POINT MUTATIONAL INACTIVATION OF THE RETINOBLASTOMA ANTIONCOGENE [J].
HOROWITZ, JM ;
YANDELL, DW ;
PARK, SH ;
CANNING, S ;
WHYTE, P ;
BUCHKOVICH, K ;
HARLOW, E ;
WEINBERG, RA ;
DRYJA, TP .
SCIENCE, 1989, 243 (4893) :937-940